Elevated Kallistatin promotes the occurrence and progression of non-alcoholic fatty liver disease.
Fang Z, Shen G, Wang Y, Hong F, Tang X, Zeng Y, Zhang T, Liu H, Li Y, Wang J, Zhang J, Gao A, Qi W, Yang X, Zhou T, Gao G.
Fang Z, et al.
Signal Transduct Target Ther. 2024 Mar 12;9(1):66. doi: 10.1038/s41392-024-01781-9.
Signal Transduct Target Ther. 2024.
PMID: 38472195
Free PMC article.